We have experience working across a broad range of small-molecule and biologic pharmaceuticals, devices and technologies, both as counsel to life sciences companies and as former company executives. Our inside and outside counsel perspective is valuable to businesses at every stage of the company life cycle—formation, financing, IP protection, clinical trials, FDA approval, product sales and marketing, and patent term extension.
We’re advising biotechs, medical device and pharmaceutical companies, research institutions, laboratories and health care institutions developing a diverse range of device and drug technologies. A short list of their work includes small molecule and biologic drugs, drug delivery systems, orthopedic implants, wound therapy systems, anti-microbial coatings and polymers, genetic therapies and diagnostics.
- Strategic creation, development and management of IP portfolios
- U.S. and foreign patent preparation, procurement, prosecution and portfolio management
- Patent term extensions
- Product clearance analysis
- Patent opinions: noninfringement, freedom-to-operate, invalidity opinions
- IP and transactional due diligence
- Hatch-Waxman counsel
- IP licensing, sale and royalty monetization
- IPRs, Post Grant Reviews and Reexaminations
- Domestic and international trademark and branding strategy
- Joint ventures and strategic alliances
- Distribution, supply and procurement agreements
- Business formation, venture capital, commercial and other financing
- Patent litigation and ANDA disputes
- Trade secrets litigation
Patents and Intellectual Property
We help clients strategically build and manage worldwide patent estates for marketed device and drug products, product candidates and related technologies at all stages of development. We counsel clients on patent infringement and validity, and should the need arise, our experienced intellectual property litigators can help enforce your patent rights or defend against allegations of infringement. We also have a robust trademark group that provides advice on branding and strategic trademark portfolio management.
Strategic Alliances and Agreements
Drug and device development often involves partnership with institutions, individuals or companies through a variety of joint ventures, alliances or licensing agreements. These often pertain to product distribution, supply, sourcing and procurement. We negotiate, execute and enforce these contracts, bringing to the table our knowledge of the science, technology and business objectives at the root of the transaction. Our experience includes agreements that bring products to market, advance development of new technologies, facilitate access to or transfer of existing technology, and open up national and international distribution networks.
Like any business, life science companies require corporate services related to starting up, financing operations or growing their business. We have extensive experience handling M&A deals and corporate transactions for private and public life sciences companies, drawing upon attorneys who bring industry and science knowledge to due diligence, negotiation and strategy. When appropriate, we collaborate with our public company team to handle SEC reporting, tender offers, IPOs, takeover attempts and other public company regulatory and transactional needs. Additionally, our tax team is at the ready to advise on a range of strategies related to tax credit finance, international tax strategy and corporate tax planning.
Our life sciences litigators constantly team up with the IP and corporate attorneys to defend your business against patent challenges, government investigations, contract disputes, product liability claims, antitrust cases, trade secrets litigation and the full range of business torts. We employ preventative strategies to manage risk and offer talented representation in any venue, whether handling settlement negotiations, arbitration, mediation, trial or appeal.